Search Results for: HCV MARKET Recent Success in
Articles
HCV MARKET - Recent Success in HCV Treatment Brings Relief to Patients but Challenges to Companies November 7, 2016
INTRODUCTION Driven by several novel regimens recently receiving approval in the US and in Europe, high cure rates exceeding...GLOBAL DELIVERY MARKET - Advanced Drug Delivery Systems: mAb, RNAi, & Breaking the Blood-Brain Barrier November 19, 2014
Kevin James, Shalini Dewan, MS, Kim Lawson, and Usha Nagavarapu believe advances in understanding human biology and diseases are opening new and exciting possibilities in the biotechnology industry. R&D spending, along with increasing competition, patent expiries, and new and emerging technologies will continue to shape growth in this market for the foreseeable future.
MARKET ANALYSIS - Unprecedented Uptake of Sovaldi & Tecfidera Paves the Way for New Optimism in Pharma November 17, 2014
Joshua Owide, GlobalData’s Director of Healthcare Industry Dynamics, believes a successful drug launch is pivotal in the corporate evolution of most innovative drug companies, allowing them to sustain growth momentum, or, as is more commonplace in the age of the blockbuster patent expiration, replenish existing revenues at risk from lower-cost equivalents.
Palisade Bio Commences Dosing in First Ulcerative Colitis Patient Cohort in Ongoing Phase 1a/b Study of PALI-2108 March 14, 2025
Palisade Bio, Inc. recently provided an update on its ongoing Phase 1a/b study of PALI-2108 for the treatment of Ulcerative...Immuno-Oncology/Cancer Therapeutics Present Strongest Innovation Pipeline in Next 5 Years January 3, 2025
Immuno-oncology (IO) drugs/cancer therapeutics represent one of the most promising areas of medical innovation in the next five years, fundamentally...Aeterna Zentaris & Ceapro Complete Merger Transaction June 3, 2024
Aeterna Zentaris Inc. and Ceapro Inc. recently announce the successful completion and closing of their all-stock merger of equals transaction (the Transaction), which was previously announced by….
Conatus Announces Receipt of $7-Million Payment From Novartis July 10, 2017
Conatus Pharmaceuticals Inc. recently announced that its exclusive license with Novartis for the global development and commercialization of emricasan has...MRC Technology Licenses Antibody to Newsummit Biopharma March 20, 2017
MRC Technology recently announced it has licensed an antibody to Newsummit Biopharma, a leading China-based drug development process solutions provider,...Achillion Shows Potential for Best-in-Disease Regimen January 6, 2015
Achillion Pharmaceuticals, Inc. recently announced positive interim results from two studies supporting a short duration, potentially best-in-disease regimen of its...FUJIFILM Completes Acquisition of Biotherapeutics Company December 18, 2014
FUJIFILM Diosynth Biotechnologies U.S.A. Inc. (FDBU), a FUJIFILM Corporation subsidiary, recently announced the completion of its acquisition of Kalon Biotherapeutics LLC,...9/5/2012 September 3, 2012
Genmab Signs Potential Billion Dollar Agreement Genmab recently announced a global license and development agreement for daratumumab (HuMax-CD38), a human...6/27/2012 June 25, 2012
Hovione Reports Significant Sales Growth Hovione recently announced that the consolidated sales for the fiscal year ended March 2012 amounted...4/25/2012 April 18, 2012
Alitair Announces Patent Allowance for Platform Delivery Technology Alitair Pharmaceuticals, Inc., a mid-stage pharmaceutical company with multiple respiratory product candidates...1/17/2012 January 12, 2012
NantWorks to Invest $85.5 Million, Creating New Jobs & Drugs California-based NantWorks, LLC, recently announced plans to locate a new...12/6/2011 December 4, 2011
Nanion's SyncroPatch 96 Convinces Big Pharma Automated Patch Clamp Users Nanion's ion channel screening platform, the SyncroPatch 96, has been...11/29/2011 November 27, 2011
Biocon Launches Haselmeier's Insulin Pen in India Haselmeier recently announced that Biocon, one of Asia's premier biotechnology companies, has launched...3/15/2011 March 13, 2011
Cytheris Announces Study Results Indicating CYT107 Expands CD4 T-Cells Cytheris SA, a clinical-stage biopharmaceutical company focused on research and development...
